Relation between digitalis binding in vivo and inhibition of sodium, potassium-adenosine triphosphatase in canine kidney.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors* / Q000302:isolation & purification; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001647:Bile Acids and Salts; D001665:Binding Sites; D002712:Chlorides / Q000494:pharmacology; D004077:Digoxin / Q000378:metabolism / Q000494:pharmacology*; D004231:Diuresis; D004285:Dogs; D004789:Enzyme Activation; D005260:Female; D066298:In Vitro Techniques; D007668:Kidney / Q000187:drug effects / Q000201:enzymology*; D007677:Kidney Function Tests; D007770:L-Lactate Dehydrogenase; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D010042:Ouabain / Q000378:metabolism / Q000494:pharmacology*; D011188:Potassium / Q000494:pharmacology; D011770:Pyruvate Kinase; D011955:Receptors, Drug; D012964:Sodium / Q000494:pharmacology / Q000652:urine; D013053:Spectrophotometry; D013997:Time Factors; D014316:Tritium; D014461:Ultracentrifugation; D014667:Vasopressins / Q000494:pharmacology
D001647:Bile Acids and Salts; D002712:Chlorides; D011955:Receptors, Drug; D014316:Tritium; D014667:Vasopressins; D010042:Ouabain; D004077:Digoxin; D000255:Adenosine Triphosphate; D012964:Sodium; D007770:L-Lactate Dehydrogenase; D011770:Pyruvate Kinase; D000251:Adenosine Triphosphatases; D008274:Magnesium; D011188:Potassium